Neuropharmacology

Article	Citations
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease	512
Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration	187
Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism	99
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator	83
Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures	69
Sex differences in vulnerability to addiction	69
Better living through understanding the insula: Why subregions can make all the difference	69
Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model	64
The cannabinoid system and microglia in health and disease	60
NMDA receptors and synaptic plasticity in the anterior cingulate cortex	51
Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders	50
Inflammation at the crossroads of COVID-19, cognitive deficits and depression	49
The tripartite glutamatergic synapse	49
Arketamine, a new rapid-acting antidepressant: A historical review and future directions	49
AMPA receptor trafficking and LTP: Carboxy-termini, amino-termini and TARPs	48
Evolution of glutamatergic signaling and synapses	47
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research	47
Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases	47
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA	46
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics	45
Ketamine and its metabolites: Potential as novel treatments for depression	44
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways	44
Lithium alleviates blood-brain barrier breakdown after cerebral ischemia and reperfusion by upregulating endothelial Wnt/β-catenin signaling in mice	43
Loss of vagal integrity disrupts immune components of the microbiota-gut-brain axis and inhibits the effect of Lactobacillus rhamnosus on behavior and the corticosterone stress response	43
New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin	42

CNS pharmacology of NKCC1 inhibitors	42
Endocannabinoids, cannabinoids and the regulation of anxiety	42
Sex differences in pain along the neuraxis	42
How does the skeletal muscle communicate with the brain in health and disease?	40
Contrasting sex-dependent adaptations to synaptic physiology and membrane properties of prefrontal cortex interneuron subtypes in a mouse model of binge drinking	40
Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction	40
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression	39
Long-term effects of maternal cannabis vapor exposure on emotional reactivity, social behavior, and behavioral flexibility in offspring	39
Clinical and therapeutic significance of genetic variation in the GRIN gene family encoding NMDARs	39
Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1−42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease	39
Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease	39
Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders	39
Promising vulnerability markers of substance use and misuse: A review of human neurobehavioral studies	38
TMS-EEG: An emerging tool to study the neurophysiologic biomarkers of psychiatric disorders	38
Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation	38
Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors	36
Canalization and plasticity in psychopathology	35
Interactions between the microbiota and enteric nervous system during gut-brain disorders	35
Astrocytes and major depression: The purinergic avenue	34
Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota	34
Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice	33
Activation of TREM2 attenuates neuroinflammation via PI3K/Akt signaling pathway to improve postoperative cognitive dysfunction in mice	33
Nucleus accumbens melanin-concentrating hormone signaling promotes feeding in a sex-specific manner	33
BET bromodomains as novel epigenetic targets for brain health and disease	32
Lithium enhances post-stroke blood-brain barrier integrity, activates the MAPK/ERK1/2 pathway and alters immune cell migration in mice	32
N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain	32
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease	31
The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants	31
Ketamine; history and role in anesthetic pharmacology	31
Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders	31
Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice	30
CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions	30
The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: A focus on human neurological and neuropsychiatric diseases	30
Extracellular ATP: A powerful inflammatory mediator in the central nervous system	30
Mechanisms of endocannabinoid control of synaptic plasticity	29
A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model	29
Glutamate transporters: Critical components of glutamatergic transmission	29
Demand for fentanyl becomes inelastic following extended access to fentanyl vapor self-administration	29
Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy	29
Kainate receptors and synaptic plasticity	29
Neurogenesis after traumatic brain injury - The complex role of HMGB1 and neuroinflammation	29
Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care	29
Membrane trafficking and positioning of mGluRs at presynaptic and postsynaptic sites of excitatory synapses	28
Sex differences in fear responses: Neural circuits	28
Pharmacological inhibition of the cGAS-STING signaling pathway suppresses microglial M1-polarization in the spinal cord and attenuates neuropathic pain	28
Glycine agonism in ionotropic glutamate receptors	28
In vivo imaging of alpha-synuclein with antibody-based PET	28
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis	28
Psychedelics therapeutics: What we know, what we think, and what we need to research	27
Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors	27

Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model	26
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery	26
Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg	26
The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice	26
Activation of locus coeruleus to rostromedial tegmental nucleus (RMTg) noradrenergic pathway blunts binge-like ethanol drinking and induces aversive responses in mice	26
Targeting the 5-HT system: Potential side effects	25
A bibliometric analysis of research on (R)-ketamine from 2002 to 2021	25
Novel ethical and policy issues in psychiatric uses of psychedelic substances	25
Noradrenergic circuits and signaling in substance use disorders	25
Ion flux-independent NMDA receptor signaling	25
Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers	25
Optogenetic manipulations of CeA-CRF neurons modulate pain- and anxiety-like behaviors in neuropathic pain and control rats	25
Cannabidiol and substance use disorder: Dream or reality	25
Sevoflurane depresses neurons in the medial parabrachial nucleus by potentiating postsynaptic GABAA receptors and background potassium channels	25
Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite	24
Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum	24
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment	24
The rostromedial tegmental (RMTg) “brake” on dopamine and behavior: A decade of progress but also much unfinished work	24
Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease	24
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex	24
Serotonin enhances depolarizing spontaneous fluctuations, excitability, and ongoing activity in isolated rat DRG neurons via 5-HT4 receptors and cAMP-dependent mechanisms	24
Trans-synaptic LGI1–ADAM22–MAGUK in AMPA and NMDA receptor regulation	24
Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman	24
Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias	24
Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine	24
Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice	23
Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases	23
Mescaline: The forgotten psychedelic	23
TRPV4 inhibitor HC067047 produces antidepressant-like effect in LPS-induced depression mouse model	23
NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia	23
Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones	23
GluA1-homomeric AMPA receptor in synaptic plasticity and neurological diseases	23
Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders	23
Danger and distress: Parabrachial-extended amygdala circuits	23
The role of CaMKII autophosphorylation for NMDA receptor-dependent synaptic potentiation	23
The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation	22
Akt / GSK3β / Nrf2 / HO-1 pathway activation by flurbiprofen protects the hippocampal neurons in a rat model of glutamate excitotoxicity	22
A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects	22
SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants	22
Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release	22
Glucocorticoid receptor modulators decrease alcohol self-administration in male rats	22
Regulation and dysregulation of neuronal circuits by KARs	22
Src and Fyn regulation of NMDA receptors in health and disease	22
Genetically selected alcohol-preferring msP rats to study alcohol use disorder: Anything lost in translation?	22
Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant	22
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse	22
mGluR1 signaling in cerebellar Purkinje cells: Subcellular organization and involvement in cerebellar function and disease	22
Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex	21
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder	21
The role of dlPFC laterality in the expression and regulation of anxiety	21
Gestational exposures to organophosphorus insecticides: From acute poisoning to developmental neurotoxicity	21
Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors	21
Lateral hypothalamus-projecting noradrenergic locus coeruleus pathway modulates binge-like ethanol drinking in male and female TH-ires-cre mice	21
Molecular, biochemical and behavioural evidence for a novel oxytocin receptor and serotonin 2C receptor heterocomplex	21
Glutamate receptors and synaptic plasticity: The impact of Evans and Watkins	21
Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus c	21
Topographic transcriptomics of the nucleus accumbens shell: Identification and validation of fatty acid binding protein 5 as target for cocaine addiction	21
Non-mitogenic fibroblast growth factor 1 protects against ischemic stroke by regulating microglia/macrophage polarization through Nrf2 and NF-κB pathways	20
Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain	20
Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin	20
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines	20
Exogenous microbiota-derived metabolite trimethylamine N-oxide treatment alters social behaviors: Involvement of hippocampal metabolic adaptation	20
MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease	20
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats	20
Reduced inhibitory and excitatory input onto parvalbumin interneurons mediated by perineuronal net might contribute to cognitive impairments in a mouse model of sepsis-associated encephalopathy	20
Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression	20
At the heart of the interoception network: Influence of the parasubthalamic nucleus on autonomic functions and motivated behaviors	20
The crosstalk between brain and periphery: Implications for brain health and disease	20
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?	20
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway	20
Sex differences in corticotropin releasing factor peptide regulation of inhibitory control and excitability in central amygdala corticotropin releasing factor receptor 1-neurons	19
The diverse and complex modes of action of anti-NMDA receptor autoantibodies	19
α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter	19
The gut-brain connection: Exploring the influence of the gut microbiota on neuroplasticity and neurodevelopmental disorders	19
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl	19
Visceral adiposity, inflammation, and hippocampal function in obesity	19
RP1, a RAGE antagonist peptide, can improve memory impairment and reduce Aβ plaque load in the APP/PS1 mouse model of Alzheimer's disease	19
Alcohol drinking during early adolescence activates microglial cells and increases frontolimbic Interleukin-1 beta and Toll-like receptor 4 gene expression, with heightened sensitivity in male rats co	19
Perturbation of maternal gut microbiota in mice during a critical perinatal window influences early neurobehavioral outcomes in offspring	19
Dysregulation of behavioral and autonomic responses to emotional and social stimuli following bidirectional pharmacological manipulation of the basolateral amygdala in macaques	19

Gut microbes and host behavior: The forgotten members of the gut-microbiome	19
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling	19
Natural and synthetic estrogens specifically alter nicotine demand and cue-induced nicotine seeking in female rats	19
Covid-19 interface with drug misuse and substance use disorders	19
Differential expression of miR-148b, miR-129-2 and miR-296 in animal models of schizophrenia-Relevance to NMDA receptor hypofunction	18
A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats	18
NPY-Y1 receptor signaling controls spatial learning and perineuronal net expression	18
Astrocyte modulation of extinction impairments in ethanol-dependent female mice	18
Hemopressin as a breakthrough for the cannabinoid field	18
The varieties of psychedelic law	18
Biology of AMPA receptor interacting proteins - From biogenesis to synaptic plasticity	18
Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation	18
Adolescent intermittent ethanol (AIE) produces sex specific alterations in adult neuroimmune gene expression and ethanol sensitivity that are independent of ethanol metabolism	18
Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies	18
Metabotropic actions of kainate receptors modulating glutamate release	18
Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota	18
Illuminating subcortical GABAergic and glutamatergic circuits for reward and aversion	18
Chronic ethanol exposure differentially alters neuronal function in the medial prefrontal cortex and dentate gyrus	18
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists	18
Kainate receptors in the developing neuronal networks	18
Olfaction in the context of obesity and diabetes: Insights from animal models to humans	18
The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression	17
The contribution of medium spiny neuron subtypes in the nucleus accumbens core to compulsive-like ethanol drinking	17
Hippocampal miR-211-5p regulates neurogenesis and depression-like behaviors in the rat	17
Glutamatergic lateral hypothalamus promotes defensive behaviors	17
The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology	17
Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal	17
Factors mediating pain-related risk for opioid use disorder	17
Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain	17
More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics	17
NMDA receptor function in inhibitory neurons	17
Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder	17
From a systems view to spotting a hidden island: A narrative review implicating insula function in alcoholism	17
Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation	17
Interoception and alcohol: Mechanisms, networks, and implications	17
Alcohol reduces the activity of somatostatin interneurons in the mouse prefrontal cortex: A neural basis for its disinhibitory effect?	17
Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice	16
Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors	16
Ropinirole, a dopamine agonist with high D3 affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults	16
Orchestration of innate and conditioned defensive actions by the periaqueductal gray	16
Losing balance: Kainate receptors and psychiatric disorders comorbidities	16
Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ9-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor	16
Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors	16
Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro	16
The evidence for and consequences of metabotropic glutamate receptor heterodimerization	16
Impact of sex, strain, and age on blood ethanol concentration and behavioral signs of intoxication during ethanol vapor exposure	16
Synaptic environment and extrasynaptic glutamate signals: The quest continues	16
Knockdown of miRNA-134-5p rescues dendritic deficits by promoting AMPK-mediated mitophagy in a mouse model of depression	16
NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research	16
PSD-95 deficiency alters GABAergic inhibition in the prefrontal cortex	16
Kainate and AMPA receptors in epilepsy: Cell biology, signalling pathways and possible crosstalk	16
The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis	16
Comparative analysis of the modulation of perineuronal nets in the prefrontal cortex of rats during protracted withdrawal from cocaine, heroin and sucrose self-administration	16
Post-ischemic stroke systemic inflammation: Immunomodulation by progesterone and vitamin D hormone	16
Reelin has antidepressant-like effects after repeated or singular peripheral injections	16
mGlu5 function in the nucleus accumbens core during the incubation of methamphetamine craving	15
Activation of ventral tegmental area neurotensin Receptor-1 neurons promotes weight loss	15
Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis	15
Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior	15
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies	15
Hippocampal NR6A1 impairs CREB-BDNF signaling and leads to the development of depression-like behaviors in mice	15
(3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) regulation of hypothalamic and extrahypothalamic corticotropin releasing factor (CRF): Sexual dimorphism and brain region specificity in Sprague Dawley rats	15
Optogenetic induction of orbitostriatal long-term potentiation in the dorsomedial striatum elicits a persistent reduction of alcohol-seeking behavior in rats	15
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice	15
NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray	15
Behavioral, hormonal, and neural alterations induced by social contagion for pain in mice	15
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments	15
Attenuated NMDAR signaling on fast-spiking interneurons in prefrontal cortex contributes to age-related decline of cognitive flexibility	15
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease	15
Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brain	15
Central amygdala mineralocorticoid receptors modulate alcohol self-administration	14
Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor a	14
Mitochondriomics reveals the underlying neuroprotective mechanism of TrkB receptor agonist R13 in the 5×FAD mice	14
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease	14
Reelin deficiency contributes to long-term behavioral abnormalities induced by chronic adolescent exposure to Δ9-tetrahydrocannabinol in mice	14
Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease	14
Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice	14
Psychedelics as preventive treatment in headache and chronic pain disorders	14
mPFC GABAergic transmission mediated the role of BDNF signaling in cognitive impairment but not anxiety induced by adolescent social stress	14
Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection	14
A sphingosine kinase 2-mimicking TAT-peptide protects neurons against ischemia-reperfusion injury by activating BNIP3-mediated mitophagy	14
Circuit and neuropeptide mechanisms of the paraventricular thalamus across stages of alcohol and drug use	14
Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors	14
Functional ultrasound imaging to study brain dynamics: Application of pharmaco-fUS to atomoxetine	14
The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity	14
The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy	14
Oxytocin mediates neuroprotection against hypoxic-ischemic injury in hippocampal CA1 neuron of neonatal rats	14
Binge ethanol drinking associated with sex-dependent plasticity of neurons in the insula that project to the bed nucleus of the stria terminalis	14
Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors	14
Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators	14
Differential modulation of the anterior cingulate and insular cortices on anxiogenic-like responses induced by empathy for pain	14
DNA methylation associated with persistent ADHD suggests TARBP1 as novel candidate	14
Reduced anterior cingulate cortex volume induced by chronic stress correlates with increased behavioral emotionality and decreased synaptic puncta density	14
A multispecies probiotic accelerates fear extinction and inhibits relapse in mice: Role of microglia	14
Similar role of mPFC orexin-1 receptors in the acquisition and expression of morphine- and food-induced conditioned place preference in male rats	13